Skip to main content
Caplight Logo









NeuralTeks

NeuralTeks

Private
Neuilly-sur-SeineEnterprise Softwarehttps://neuralteks.com/

Last Round

Seed

Jan 29, 2025

Est. Valuation

$3M

Total Funding Raised

$240,000

Company Overview

NeuralTeks is a healthtech company that develops an AI-driven multimodal platform for laboratory image analysis to enhance microbiological studies.

Sector

Enterprise Software

Verticals

Workflow Automation, E-commerce

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

custom software developmentstaff augmentationIT consultingsoftware outsourcingdev shopmicrobiological diagnosticsAI-driven diagnosticsautomated vision analysisdigital transformationmobile app developmentweb developmentnearshore developmenttechnical staffingSaaSlab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuralTeks Comparables

Compare NeuralTeks with similar companies based on industry and business-model similarity.

NeuralTeks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImageProVision Technology Pvt. Ltd.
45%

NeuralTeks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 29, 2025
AcceleratorNov 6, 2024
AcceleratorSep 9, 2024

Key People

Founding team and executive leadership

Souheil Hanoune

Co-Founder and CTO

Founding Team

Mehdi Nasreddine-Royer

Co-Founder & CEO

Founding Team

NeuralTeks Investors

Notable investors and investment history

NeuralTeks investors
InvestorRounds
Paris Biotech SantéSeed
TechstarsSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 3, 2025

    Monthly visitors grew 343% MoM, from 54 to 239.

NeuralTeks Filings

Explore SEC and related filing metadata, where available.

NeuralTeks filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuralTeks's valuation, stock price, and market status.

Is NeuralTeks a public or private company?

NeuralTeks is a private company.

What is the current stock price of NeuralTeks?

NeuralTeks is a private company with no public stock price. No recent secondary market data is available.

How much is NeuralTeks worth (valuation)?

Valuation information for NeuralTeks is not publicly available.

Can I buy NeuralTeks stock?

NeuralTeks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuralTeks's last funding round?

NeuralTeks's most recent funding round was Seed on January 29, 2025.

Who are the main investors in NeuralTeks?

Key investors in NeuralTeks include Techstars.

Will NeuralTeks IPO soon?

No public IPO plans have been announced for NeuralTeks.

How can I track NeuralTeks secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuralTeks's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNeuilly-sur-Seine
Employee Range5
Year Founded2024
Last FundingJan 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?